Author

Yuma Nihashi

Cellular and Molecular Biotechnology Research InstituteORCID 0000-0002-5689-116XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Koji UmezawaiD· 2 shared Takeshi ShimosatoiD· 2 shared Tomohide TakayaiD· 2 shared Chihaya Kimura· 1 shared Hiroshi KAGAMI· 1 shared R. Ikeda· 1 shared Rena Ikeda· 1 shared Sayaka Shinji· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Koji UmezawaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyLifePeer-reviewedNov 30, 2024

Osteogenic CpG oligodeoxynucleotide, iSN40, inhibits osteoclastogenesis in a TLR9-dependent manner

R. Ikeda, Chihaya Kimura, Yuma Nihashi…·Tomohide Takaya

This study shows that iSN40, a CpG-ODN, inhibits osteoclast formation via TLR9-dependent mechanisms and may be a therapeutic for osteoporosis.

1 citation

mouseexperimental assay

𝕏 PostBluesky

Cell BiologyBioTechPeer-reviewedApr 25, 2024

Development of the 12-base short dimeric myogenetic oligodeoxynucleotide that induces myogenic differentiation

Koji Umezawa, Rena Ikeda, Taiichi Sakamoto…·Tomohide Takaya

This paper develops a 12-base myogenetic oligodeoxynucleotide that maintains the myogenic activity of a longer sequence while improving drug efficacy and synthesis cost.

2 citations

humanDNA methylation

𝕏 PostBluesky